Yahoo Canada Web Search

Search results

  1. Chan Shen, PhD. Professor, Department of Surgery. Associate Professor, Department of Surgery. Chief, Division of Outcomes, Research and Quality. Scientific Program: Cancer Control. CZS5992@psu.edu.

  2. en.wikipedia.org › wiki › Chan_ShenChan Shen - Wikipedia

    Chan Shen (11 March 1940 - 26 April 1984) was a Taiwanese -born Hong Kong film actor. He is best known for his roles as gangsters or villains in Hong Kong action cinema in the 1970s. Already an established film actor in Taiwan, he entered the Hong Kong film industry in 1971.

  3. Chan Shen, PhD. Professor, Department of Surgery. Chief, Division of Outcomes, Research and Quality. Penn State Cancer Institute. Cancer Institute, Cancer Control. h-index. 4632. Citations. 23.

  4. May 2, 2022 · Objectives: To critically examine the factors associated with clinically relevant improvement in OS (defined as ≥2 months) in these trials and to evaluate their association with outcomes reflected in Surveillance, Epidemiology, and End Results (SEER) registry data.

  5. Receptor, ErbB-2. Surgery in addition to ST has a survival benefit for stage IV breast cancer patients with known hormone receptor and HER2 status and should be considered after NAC for patients with ER+, PR+, or HER2+ disease.

    • Kelly Stahl, William Wong, Daleela Dodge, Ashton Brooks, Christopher McLaughlin, Elizabeth Olecki, J...
    • 2021
  6. Jan 7, 2022 · Abstract. Background: Early-onset pancreatic cancer (EOPC) is relatively uncommon. It is unclear if the incidence of EOPC is evolving and how these patients are treated. Methods: We conducted a retrospective, population-based study using SEER 2004-2016.

  7. Nov 25, 2022 · We identified patients aged 70 to 90 years old newly diagnosed in 2010–2015 with early-stage, hormone receptor positive, and human epidermal growth factor receptor 2 (HER2) negative (HR+/Her2−) breast cancer who received lumpectomy and omitted radiation therapy using the SEER-Medicare database.